Tim Lugo

Chief Financial Officer at Latigo Biotherapeutics.

Raised on Latigo Biotherapeutics filings

$50M

of $150M offered across 1 Form D filing

Company

Biotech · Thousand Oaks, CA

Non-opioid pain medicines

Non-opioid pain medicines

Latigo Biotherapeutics Form D filings
Filed	Security	Sold of offered	Filing
Feb 13, 2025	Equity	$50M/ $150M	Form D